18F-FDOPA PET Imaging in Prolactinoma
- PMID: 28590300
- DOI: 10.1097/RLU.0000000000001721
18F-FDOPA PET Imaging in Prolactinoma
Abstract
Pituitary macroadenoma constitutes a frequently misdiagnosed benign tumor. We report herein a case where such macroadenoma, a prolactinoma, was incidentally discovered in a 63-year-old man who had been referred to F-FDG PET and F-FDOPA PET imaging for a pharmacoresistant epilepsy. An increased uptake was documented for both radiotracers within the sellar region, although with a much higher contrast for F-FDOPA than for F-FDG. This case presents an increased uptake documented within a prolactinoma owing to the high contrast and image quality provided by F-FDOPA PET.
Similar articles
-
18F-FDOPA Uptake Reflects the Efficacy of Dopamine Agonists Treatment in Pituitary Prolactinoma.Clin Nucl Med. 2018 Sep;43(9):e324-e325. doi: 10.1097/RLU.0000000000002202. Clin Nucl Med. 2018. PMID: 30052596
-
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.J Nucl Med. 2006 Jun;47(6):904-11. J Nucl Med. 2006. PMID: 16741298 Clinical Trial.
-
68Ga DOTATATE PET/CT of Synchronous Meningioma and Prolactinoma.Clin Nucl Med. 2016 Mar;41(3):230-1. doi: 10.1097/RLU.0000000000001021. Clin Nucl Med. 2016. PMID: 26462040
-
Role of (18) F-FDOPA PET/CT imaging in endocrinology.Clin Endocrinol (Oxf). 2014 Dec;81(6):789-98. doi: 10.1111/cen.12566. Epub 2014 Sep 1. Clin Endocrinol (Oxf). 2014. PMID: 25056984 Review.
-
18F-FDOPA PET for the diagnosis of parkinsonian syndromes.Q J Nucl Med Mol Imaging. 2014 Dec;58(4):355-65. Epub 2014 Nov 4. Q J Nucl Med Mol Imaging. 2014. PMID: 25366711 Review.
Cited by
-
DRD2 expression based on 18F-fallypride PET/MR predicts the dopamine agonist resistance of prolactinomas: a pilot study.Endocrine. 2023 May;80(2):419-424. doi: 10.1007/s12020-023-03310-0. Epub 2023 Jan 23. Endocrine. 2023. PMID: 36689171
-
EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours.Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2367-2370. doi: 10.1007/s00259-024-06728-4. Eur J Nucl Med Mol Imaging. 2024. PMID: 38687371 No abstract available.
-
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2112-2137. doi: 10.1007/s00259-019-04398-1. Epub 2019 Jun 29. Eur J Nucl Med Mol Imaging. 2019. PMID: 31254038 Free PMC article.
-
Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: A 18 F-FDOPA PET/CT study.Head Neck. 2019 Jun;41(6):1565-1571. doi: 10.1002/hed.25604. Epub 2018 Dec 24. Head Neck. 2019. PMID: 30584686 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical